S2EP9: Going Public via a Reverse-Merger with Sabrina Johnson

She had the science, the credentials, and a market that encompassed half the population. The people with the capital just didn't care enough about women's health to bet on it. So she stopped trying to convince them. In this episode of The Capital Flex, I sit down with Sabrina Martucci Johnson, founder and CEO of Daré Bioscience, the only publicly traded company on any exchange working solely in women's health. Daré builds science-backed solutions for women across contraception, menopause, aro...